Immunohistochemical assessment of the diagnostic utility of PD‐L1: a preliminary analysis of anti‐PD‐L1 antibody (SP142) for lymphoproliferative diseases with tumour and non‐malignant Hodgkin–Reed‐Sternberg (HRS)‐like cells

Volume: 72, Issue: 7, Pages: 1156 - 1163
Published: Mar 9, 2018
Abstract
Aims The programmed death 1 ( PD 1)/ PD 1 ligand ( PD ‐L1) axis plays an important role in tumour cells escape from immune control. PD ‐L1 immunohistochemistry is a useful predictor of immunotherapy response, but is still not used widely in the diagnostic setting. Here we describe results using PD ‐L1 immunohistochemistry during routine diagnostics in lymphoma. Methods and results Ninety‐one lymphoproliferative disease cases sharing tumour and...
Paper Details
Title
Immunohistochemical assessment of the diagnostic utility of PD‐L1: a preliminary analysis of anti‐PD‐L1 antibody (SP142) for lymphoproliferative diseases with tumour and non‐malignant Hodgkin–Reed‐Sternberg (HRS)‐like cells
Published Date
Mar 9, 2018
Volume
72
Issue
7
Pages
1156 - 1163
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.